NEW YORK, Sept. 6 (GenomeWeb News) - Avestha Gengraine Technologies, a bioinformatics company based in India, will help Ranbaxy Laboratories develop recombinant cell lines as part of a drug-discovery program, the companies said today.


Avestha Gengraine's research covers infectious diseases and degenerative and metabolic disorders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.